Dordaviprone
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Emerging Targeted Therapies and Ongoing Clinical Trials in Pediatric Brain Tumors
Journal: No shinkei geka. Neurological surgery
Published: December 09, 2025
ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Dordaviprone in H3K27M-mutant diffuse midline glioma: an editorial on emerging targeted therapy.
Journal: Annals of medicine and surgery (2012)
Published: September 27, 2025
Dordaviprone (Modeyso) for diffuse midline glioma.
Journal: The Medical letter on drugs and therapeutics
Published: September 22, 2025
ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.
Journal: Neuro-oncology
Published: September 18, 2025
Molecular mechanisms of mitochondrial AAA+ proteases.
Journal: The Journal of biological chemistry
Published: September 18, 2025
Dordaviprone Hydrochloride.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: September 08, 2025
Hybrid GPP-hospital control strategy for semi-solid extrusion 3D printing of ONC201 chewable units in pediatric oncology.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: August 22, 2025
Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic Benefit.
Journal: Current issues in molecular biology
Published: August 13, 2025
A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Dordaviprone.
Journal: Journal of clinical pharmacology
Published: August 07, 2025
Last Updated: 04/28/2026